Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 80 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Cognitive Effects of Cancer and Cancer Treatments
Tim A. Ahles, James C. Root
Annual Review of Clinical Psychology (2018) Vol. 14, Iss. 1, pp. 425-451
Open Access | Times Cited: 274
Apolipoprotein E in lipid metabolism and neurodegenerative disease
Linda Yang, Zachary M. March, Roxan A. Stephenson, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 8, pp. 430-445
Open Access | Times Cited: 73
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Jeanne S. Mandelblatt, Brent J. Small, George Luta, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3211-3222
Open Access | Times Cited: 153
Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats
Naomi Lomeli, Kaijun Di, J Czerniawski, et al.
Free Radical Biology and Medicine (2016) Vol. 102, pp. 274-286
Open Access | Times Cited: 137
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Taxane‐induced neurotoxicity: Pathophysiology and therapeutic perspectives
Robson da Costa, Giselle F. Passos, Nara Lins Meira Quintão, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3127-3146
Open Access | Times Cited: 96
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients
Sabine Deprez, Shelli R. Kesler, Andrew J. Saykin, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 3, pp. 223-231
Open Access | Times Cited: 84
Changes in Brain Structural Networks and Cognitive Functions in Testicular Cancer Patients Receiving Cisplatin-Based Chemotherapy
Ali Amidi, S. M. Hadi Hosseini, Alexander Leemans, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 12
Open Access | Times Cited: 81
Testicular Cancer Survivorship
Chunkit Fung, Paul C. Dinh, Sophie D. Fosså, et al.
Journal of the National Comprehensive Cancer Network (2019) Vol. 17, Iss. 12, pp. 1557-1568
Open Access | Times Cited: 69
Genetic risk factors for cancer-related cognitive impairment: a systematic review
Cecilie D. R. Buskbjerg, Ali Amidi, Ditte Demontis, et al.
Acta Oncologica (2019) Vol. 58, Iss. 5, pp. 537-547
Open Access | Times Cited: 43
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 42
A narrative review of risk factors and interventions for cancer- related cognitive impairment
Lu Bai, Enyan Yu
Annals of Translational Medicine (2021) Vol. 9, Iss. 1, pp. 72-72
Open Access | Times Cited: 36
Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study
Mylène Duivon, François Christy, Emilie Thomas, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients
Lisa M. Wu, Ali Amidi
Current Opinion in Supportive and Palliative Care (2016) Vol. 11, Iss. 1, pp. 38-45
Open Access | Times Cited: 40
An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI)
Laura Catalina Murillo, Jhon Jairo Sutachan, Sonia Luz Albarracín
Toxicology Reports (2023) Vol. 10, pp. 544-553
Open Access | Times Cited: 12
Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis
Michiel B. de Ruiter, Rachael Deardorff, Jeroen Blommaert, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 5, pp. 507-518
Closed Access | Times Cited: 12
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study
Mylène Duivon, Justine Lequesne, Antonio Di Meglio, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
CNS Side Effects of Immune Checkpoint Inhibitors: Preclinical Models, Genetics and Multimodality Therapy
Gwendolyn J. McGinnis, Jacob Raber
Immunotherapy (2017) Vol. 9, Iss. 11, pp. 929-941
Open Access | Times Cited: 37
Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors
Michal Chovanec, Lucia Vasiľková, Lucia Setteyova, et al.
The Oncologist (2018) Vol. 23, Iss. 5, pp. 617-623
Open Access | Times Cited: 36
Chemotherapy-induced cognitive impairments: White matter pathologies
A. Matsos, Max Loomes, Iris Y. Zhou, et al.
Cancer Treatment Reviews (2017) Vol. 61, pp. 6-14
Closed Access | Times Cited: 34
Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation
Aasha I. Hoogland, Ashley Nelson, Brian D. Gonzalez, et al.
Brain Behavior and Immunity (2019) Vol. 80, pp. 308-314
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top